Immune checkpoint inhibitors in HBV-caused hepatocellular carcinoma therapy
J Zhang, C Hu, X Xie, L Qi, C Li, S Li - Vaccines, 2023 - mdpi.com
Hepatitis B virus (HBV) infection is the main risk factor for the development of hepatocellular
carcinoma (HCC), the most common type of liver cancer, with high incidence and mortality
worldwide. Surgery, liver transplantation, and ablation therapies have been used to treat
early HBV-caused HCC (HBV-HCC); meanwhile, in the advanced stage, chemoradiotherapy
and drug-targeted therapy are regularly considered, but with limited efficacy. Recently,
immunotherapies, such as tumor vaccine therapy, adoptive cell transfer therapy, and …
carcinoma (HCC), the most common type of liver cancer, with high incidence and mortality
worldwide. Surgery, liver transplantation, and ablation therapies have been used to treat
early HBV-caused HCC (HBV-HCC); meanwhile, in the advanced stage, chemoradiotherapy
and drug-targeted therapy are regularly considered, but with limited efficacy. Recently,
immunotherapies, such as tumor vaccine therapy, adoptive cell transfer therapy, and …
[引用][C] Immune Checkpoint Inhibitors in HBV-Caused Hepatocellular Carcinoma Therapy. Vaccines 2023, 11, 614
J Zhang, C Hu, X Xie, L Qi, C Li, S Li - 2023 - europepmc.org
Hepatitis B virus (HBV) infection is the main risk factor for the development of hepatocellular
carcinoma (HCC), the most common type of liver cancer, with high incidence and mortality
worldwide. Surgery, liver transplantation, and ablation therapies have been used to treat
early HBV-caused HCC (HBV-HCC); meanwhile, in the advanced stage, chemoradiotherapy
and drugtargeted therapy are regularly considered, but with limited efficacy. Recently,
immunotherapies, such as tumor vaccine therapy, adoptive cell transfer therapy, and …
carcinoma (HCC), the most common type of liver cancer, with high incidence and mortality
worldwide. Surgery, liver transplantation, and ablation therapies have been used to treat
early HBV-caused HCC (HBV-HCC); meanwhile, in the advanced stage, chemoradiotherapy
and drugtargeted therapy are regularly considered, but with limited efficacy. Recently,
immunotherapies, such as tumor vaccine therapy, adoptive cell transfer therapy, and …
以上显示的是最相近的搜索结果。 查看全部搜索结果